Andreessen Horowitz backs Synonym’s bio-manufacturing facilities
TechCrunch
OCTOBER 14, 2022
million in new pre-seed capital, Synonym Biotechnologies has begun the development phase for its first productized bio-manufacturing facilities for non-pharmaceutical applications. The global contract bio-manufacturing organization market, which venture-backed startups like Planetary and Culture Biosciences are doing, was estimated to be $22.2
Let's personalize your content